Blog
Why Shares of Erasca Are Jumping Tuesday
Shares of Erasca (NASDAQ: ERAS) were up more than 12% as of 3 p.m. on Tuesday after a big insider buy. The healthcare company's stock is down more than 43% this year.
Erasca is a clinical-stage
Why Clean Energy Stocks Lucid Motors, Plug Power, and NextEra Energy Partners Surged Today
Shares of Lucid Motors (NASDAQ: LCID), Plug Power (NASDAQ: PLUG), and NextEra Energy Partners (NYSE: NEP) had rallied by 6.6%, 11.1%, and 8.3%, respectively, as of 2 p.m. ET Tuesday.
These three
Why Canopy Growth Stock Spiked Today
Shares of Canada-based Canopy Growth (NASDAQ: CGC) popped Tuesday, but not because of its Canadian marijuana business. Canopy shares soared by as much as 14.5% in early trading, and remained up by
Why Truist Stock Was Climbing Today
Shares of Truist Financial (NYSE: TFC) were moving higher Tuesday on reports that the bank could sell its insurance brokerage for roughly $10 billion.
As a result, the stock was up 6.2% as of 2:25
Why PGT Innovations Stock Popped Today
Shares of PGT Innovations (NYSE: PGTI) were up 21.1% as of 1 p.m. ET after a report that the storm window and door manufacturer rebuffed an acquisition offer from Koch Industries-backed window and
Down 45%, Is Intellia a Buy?
Intellia Therapeutics (NASDAQ: NTLA) has announced a good deal of positive news in recent months, from progress in clinical trials to an expanded partnership with big biotech Regeneron
Why Coca-Cola Stock Was Moving Higher Today
After sliding during most of the past month on fears that weight-loss drugs like Ozempic would sap some of its demand, Coca-Cola (NYSE: KO) stock was moving higher in tandem with Pepsico (NASDAQ:
Why Solar Energy Stocks Are On Fire Today
Shares of solar energy stocks soared on Tuesday after a fairly negative report by one of the industry's suppliers. This may be more about the market seeing the worst is over for the residential
Why Shares of Ventyx Biosciences Are Dropping Tuesday
Shares of Ventyx Biosciences (NASDAQ: VTYX) were down more than 26% as of noon on Tuesday after investors were unimpressed by the healthcare company's phase 2 trial results for ulcerative colitis
Why Rivian Automotive Stock Popped Today
Shares of Rivian Automotive (NASDAQ: RIVN) popped this morning, rebounding from a decline that began last week. After gaining as much as 6.4%, the stock of the electric vehicle (EV) maker was higher
Why Coherent Stock Jumped on Tuesday
Shares of Coherent (NYSE: COHR) were up 10% as of 11:33 a.m. ET on Tuesday after the company said its silicon carbide semiconductor business will receive $1 billion in investments from two Japanese
Massive News for Workhorse Stock Investors
Fool.com contributor Parkev Tatevosian takes a step-by-step approach to the recent developments at Workhorse Group (NASDAQ: WKHS) in this brief video.
*Stock prices used were the afternoon prices
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought
Cathie Wood hit the new trading week running. The Ark Invest co-founder, CEO, and chief stock picker added to seven of her existing positions on Monday. She didn't sell a single stock.
What is she
Why Akero Therapeutics Stock Is Crashing Today
Shares of Akero Therapeutics (NASDAQ: AKRO) were crashing 66.5% lower as of 11:09 a.m. ET on Tuesday. The steep decline came after the company announced interim results from a phase 2b clinical
Why Shares of Lexicon Pharmaceuticals Are Up Tuesday
Shares of Lexicon Pharmaceuticals (NASDAQ: LXRX) were up more than 15% as of 11 a.m. on Tuesday after Express Scripts said it will give certain clients access to Lexicon's drug Inpefa. The healthcar
2 Trillion-Dollar Stocks You'll Want to Buy in October Like They're Going Out of Style
The technology industry has created more value for investors than any other in U.S. history. All five American companies with valuations topping $1 trillion operate in the tech sector.
While many
Amazon Stock: Buy, Sell, or Hold?
Amazon (NASDAQ: AMZN) doesn't need an introduction, as I'm sure most readers are customers of the tech enterprise. Due to the company's outstanding success, it has made for a wonderful investment.
Unity Software Just Lost Its CEO -- Why Is the Stock Rallying?
In today's video, I discuss recent updates impacting Unity Software (NYSE: U). Check out the short video to learn more, consider subscribing, and click the special offer link below.
*Stock prices
Why Acadia Pharmaceuticals Stock Is Rising Today
Acadia Pharmaceuticals (NASDAQ: ACAD) is having a strong session Tuesday. Specifically, the drugmaker's shares were up by a healthy 6.7% on moderate volume at 10:02 a.m. ET.
What's sparking this
4 Reasons to Buy Rivian Automotive Stock, and 1 Reason to Sell
Rivian Automotive (NASDAQ: RIVN) was one of the hottest IPOs of 2021. The electric vehicle (EV) maker went public at $78, and its shares more than doubled to a record high of $172.01 less than a
1 Magnificent Nasdaq-100 Stock to Buy and Hold Forever
While the Nasdaq-100 index is more famous for its technology-focused companies, it is also home to a handful of successful consumer discretionary stocks.
One of these is car-parts specialist
3 Stocks That Can Help Build Generational Wealth for Patient Investors
Many folks are lured into the stock market by tales of getting rich quick through explosive growth stocks. But there's a far simpler, less stressful way of building generational wealth that also
New to Fintech? Here's Why I Would Buy Visa Stock First
Are you looking to add financial technology (fintech) stocks to your portfolio? That's probably a good idea. Fintech focuses on innovating the way money moves through the global economy.
The global
This Cathie Wood Stock Is Poised to Double, Says Wall Street
Gene-editing specialist Intellia Therapeutics (NASDAQ: NTLA) has caught the attention of Cathie Wood. The founder and CEO of Ark Invest, an investment management firm focused on investing in
Down 21%, Is This Favorite Warren Buffett Stock Now a Sell?
While Apple might be Berkshire Hathaway's biggest holding, Warren Buffett's favorite is arguably Coca-Cola (NYSE: KO). Coke is Berkshire's longest-held investment, sitting in its portfolio for 35


